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Primary MicroRNA Processing Assay Reconstituted Using 
Recombinant Drosha and DGCR8
Ian Barr and Feng Guo
Abstract
In animals, the Microprocessor complex cleaves primary transcripts of microRNAs (pri-miRNAs) 
to produce precursor microRNAs in the nucleus. The core components of Microprocessor include 
the Drosha ribonuclease and its RNA-binding partner protein DiGeorge critical region 8 
(DGCR8). DGCR8 has been shown to tightly bind an Fe(III) heme cofactor, which activates its 
pri-miRNA processing activity. Here we describe how to reconstitute pri-miRNA processing using 
recombinant human Drosha and DGCR8 proteins. In particular, we present the procedures for 
expressing and purifying DGCR8 as an Fe(III) heme-bound dimer, the most active form of this 
protein, and for estimating its heme content.
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1 Introduction
1.1 The Microprocessor Complex
The Microprocessor complex minimally contains the proteins Drosha [1], an RNase III 
family member, and DGCR8 [2, 3], an RNA-binding protein that also contains the cofactor 
heme [4–6]. Drosha and DGCR8 are essential for processing of all canonical microRNAs 
(miRNAs) in animals [7–9]. They are also sufficient to reconstitute pri-miRNA processing 
activity in vitro [3, 10]. Furthermore, quite a few proteins have been shown to regulate the 
Drosha/DGCR8-mediated cleavage of pri-miRNAs [11–18].
The domain structures of Drosha and DGCR8 have been dissected in several studies. Drosha 
contains two RNase III domains and a double-stranded RNA-binding domain (dsRBD) in 
the C-terminal region (Fig. 1a). The central region of Drosha, including residues 390–900, is 
highly conserved and required for pri-miRNA processing but contains no recognizable 
sequence motifs [10, 19]. DGCR8 contains a heme-binding domain, two dsRBDs, and a C-
terminal tail (CTT) (Fig. 1b). The dsRBDs contribute to pri-miRNA binding [4, 20, 21]. The 
C-terminal tail has been shown to be important for co-immunoprecipitation of DGCR8 with 
Drosha in human cells [10] and for formation of proper higher order structure of DGCR8 
upon binding pri-miRNAs [22]. See a recent review for more background information [23].
HHS Public Access
Author manuscript
Methods Mol Biol. Author manuscript; available in PMC 2016 March 11.
Published in final edited form as:
Methods Mol Biol. 2014 ; 1095: 73–86. doi:10.1007/978-1-62703-703-7_5.
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
pri-miRNA processing may be analyzed in vitro using either whole-cell or nuclear extracts 
[24, 25], affinity-purified Microprocessor complexes expressed in mammalian cells [19, 26–
28], or recombinant Drosha and DGCR8 expressed in heterologous systems [3, 10]. We 
focus on the last method in this review. Insect cell and bacterial expression systems allow 
active Drosha and DGCR8 proteins to be expressed with high yield and be purified to near 
homogeneity. These highly purified proteins do not contain other human proteins typically 
found to associate with Drosha and DGCR8 and enable the investigation of pri-miRNA 
processing with greater control of the experimental conditions.
Gregory, Shiekhattar, and colleagues were the first to show that Microprocessor may be 
reconstituted by expressing Drosha in insect cells and DGCR8 in E. coli [3]. The N-terminal 
275 amino acids [10, 20] and the C-terminal 22/23 residues [4, 20] of the 773-residue 
DGCR8 have been shown to be dispensable for in vitro pri-miRNA processing. A DGCR8 
construct with these residues deleted (named NC1, Fig. 1b) is the most active form in pri-
miRNA processing in vitro, whereas a further truncation called NC9 (Fig. 1b), containing 
only the two dsRBDs and the CTT, is less active than NC1 [6]. The procedures for 
expression and purification of NC1 are described in this review.
1.2 DGCR8 as a Heme Protein
In addition to being an obligate partner of Drosha, DGCR8 also binds heme [4]. The central 
region of DGCR8, including the WW motif, encodes a unique dimeric heme-binding 
domain [29]. Each DGCR8 dimer binds one heme molecule [4]. The heme in native 
DGCR8, expressed in E. coli, is in the Fe(III) redox state [5]. DGCR8 ligates to the Fe(III) 
using two Cys352 side chains contributed by both subunits; this coordination configuration 
results in characteristic absorption peaks at 366, 450, and 556 nm (Fig. 2) [5]. Recently, we 
show that Fe(III) heme activates dimeric apoNC1 for pri-miRNA processing in vitro, 
whereas Fe(II) heme does not [6]. Dimerization and heme binding are likely conserved 
properties of DGCR8 in all vertebrates and at least some invertebrates such as the star fish 
Patiria miniata [30]. Heme and the heme-binding domain appear to be important for pri-
miRNA processing both in vitro and in vivo ([4, 6, 29] and our unpublished data), though 
their physiological functions have not been determined.
In order to obtain consistent results in studying pri-miRNA processing and to interpret them 
properly, it is important to express and purify recombinant DGCR8 protein with optimal 
heme content. When NC1 is overexpressed in E. coli, a heme-deficient condition is 
generated and hence some heme-free protein is produced [4]. The heme-free NC1 may 
appear as dimer and monomer [4, 6]. At least a part of the latter species is actually 
heterodimer of NC1, in which a subunit is cleaved by bacterial proteases during 
overexpression and/or purification so that only a small fragment (the dimerization domain) 
is left bound to the intact subunit [29]. The heme content of DGCR8 is indicated by the 
A450 nm/A280 nm ratio, if the protein is purified to be free of nucleic acids from expression 
hosts. It is also possible to prepare apoNC1 from Fe(III) heme-bound NC1 via reduction and 
heme removal for studying activation of DGCR8 by heme [6]. However, the preparation of 
apoNC1 is beyond the scope of this chapter.
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1.3 Preparation of Recombinant Drosha Protein
Full-length Drosha expressed in insect cells has been used in several studies [3–5, 22, 29]. 
However, in our experience the full-length His6-Drosha is poorly soluble and cannot be 
purified using either Ni affinity or ion-exchange chromatography; and only a small amount 
of partially purified active His6-Drosha may be obtained using size exclusion 
chromatography [4]. The N-terminal 390 amino acid residues of Drosha are dispensable for 
in vitro activity [10]. Recently, we found that truncation of this region greatly improves the 
solubility of Drosha without compromising the activity [6]. The procedure for purifying 
His6-Drosha390–1374 is described below.
1.4 Design of pri-miRNA Constructs for Reconstituted pri-miRNA Processing Assay
miRNAs may reside in introns or exons, messenger RNAs or independent transcripts [31]. 
Processing of pri-miRNAs by Microprocessor occurs co-transcriptionally [32]. Intronic pri-
miRNAs may be processed by Drosha before splicing catalysis [33]. The exact 5′ and 3′ 
ends of pri-miRNAs at the time of processing are often not known. Biochemical studies 
show that pri-miRNA fragments containing the precursor miRNA (pre-miRNA) and certain 
lengths of the immediate flanking regions can be processed by Drosha and DGCR8 [1, 24]. 
The minimal lengths of the flanking regions for efficient processing by affinity-purified 
Microprocessor complexes may be as short as 10–20 nt [10, 19]. For reconstituted pri-
miRNA processing assays, we typically include 30–60 nt on both sides of the pre-miRNA 
region.
The pri-miRNA fragments are typically prepared using T7 or SP6 RNA polymerase. The 
protocol for how to use T7 RNA polymerase is provided here. The transcription template 
should contain the T7 promoter, followed by the pri-miRNA coding sequence. For high 
transcription yields, the first two nucleotides of the transcript should be guanosines [34]. 
Either a PCR product or a linearized plasmid may serve as the template for the run-off 
transcription, in which the 3′-end of the RNA is roughly defined by the end of the template 
where the RNA polymerase simply falls off. The T7 RNA polymerase is known to add 0–3 
non-templated residues at the 3′-end of the transcripts [34]. In the case where a plasmid 
template is used, a cleavage site for a restriction endonuclease such as PstI or EarI is 
engineered for linearization.
2 Materials
All solutions should be, to the greatest extent possible, free from RNase contamination. This 
applies especially to the reagents and buffers involved in transcription and pri-miRNA 
processing reactions and in the storage of RNAs.
2.1 Expression and Purification of DGCR8
1. The NC1 expression plasmid contains the coding sequence of amino acid residues 
276–751 (NCBI accession no. of full-length DGCR8 cDNA: BC037564) inserted 
between NdeI and EcoRI sites of pET-24a(+) (kanamycin resistant) or pET-17b 
(ampicillin resistant) vector. The PCR primers used in cloning are 
CAGCCATATGGATGGAGAGACAAGTGTGC (forward, the NdeI site 
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underlined) and GCTCGAATTCACTTTCGAGTCTCCTCCCT (reverse, the 
EcoRI site underlined).
2. E. coli strain BL21-CodonPlus (DE3)-RIPL (Agilent Technologies).
3. LB-Miller medium.
4. UV-visible absorption spectrophotometer equipped with a turbidity cuvette holder.
5. Isopropyl β-D-1-thiogalactopyranoside (IPTG).
6. δ-aminolevulinic acid (δ-ALA).
7. High-speed centrifuge.
8. Sonics Vibra-Cell VCX 750 ultrasonic processor equipped with a standard probe.
9. Chromatography systems such as ÄKTA Purifier and ÄKTA Prime.
10. 5-mL HiTrap SP HP cation exchange column (GE Healthcare).
11. Superdex 200 10/300 GL gel filtration column (GE Healthcare).
12. DGCR8 lysis buffer: 20 mM Tris–HCl pH 8.0, 100 mM NaCl, 1 mM 
phenylmethylsulfonyl fluoride (PMSF), 1 mM dithiothreitol (DTT) (see Note 1).
13. DGCR8 buffer A: 20 mM Tris–HCl pH 8.0, 100 mM NaCl, 1 mM DTT.
14. DGCR8 buffer B: 20 mM Tris–HCl pH 8.0, 2 M NaCl, 1 mM DTT.
15. SEC buffer: 20 mM Tris–HCl pH 8.0, 400 mM NaCl, 1 mM DTT.
16. Centrifugal concentrator with a molecular weight cutoff of 30 kDa.
2.2 Expression and Purification of Drosha
1. The His6-Drosha390–1374 expression plasmid has the coding sequence of amino 
acid residues 390–1,374 of human Drosha (NCBI accession no. of full-length 
cDNA: NM_013235) inserted between BamHI and NotI sites of pFastBac-HTb 
vector. The PCR primers used in cloning are 
CGCGGATCCAAAGAGCCCGAGGAGACC (forward, the BamHI site 
underlined) and 
GAGGATTAGAGCGGCCGCTTATTTCTTGATGTCTTCAGTCTC (reverse, the 
NotI site underlined). The recombinant His6-Drosha390–1374 contains a His6-tag 
and a TEV cleavage site at its N-terminus (see Note 2).
2. Sf9 insect cells, culture medium, and transfection reagent.
3. Equipment same as the ones described for DGCR8 purification.
4. Ni Sepharose High Performance column (GE Healthcare).
1The reducing reagent DTT (or β-mercaptoethanol) is important for keeping DGCR8 active. Make sure that your DTT stock solution 
is in a fully reduced state. Solutions of reduced DTT should have minimal absorbance above 250 nm, while oxidized DTT has an 
absorbance peak at 283 nm with an extinction coefficient of 273 M−1 cm−1 [36]. We store our DTT stock solution (1 M) in −20 °C in 
aliquots and avoid repeated freeze and thaw.
2The TEV cleavage site in His6-Drosha390–1374 allows the His6-tag to be cleaved off using the TEV protease if desired but is not 
used in the protocol presented here.
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5. Drosha lysis buffer: 20 mM Tris–HCl (pH 8.0), 500 mM NaCl, 10 mM imidazole, 
20 % (v/v) glycerol, and 0.83 mM PMSF.
6. Drosha wash buffer: 20 mM Tris–HCl (pH 8.0), 500 mM NaCl, 10 mM imidazole, 
and 20 % (v/v) glycerol.
7. Drosha elution buffer: 20 mM Tris–HCl (pH 8.0), 500 mM NaCl, 200 mM 
imidazole, and 20 % (v/v) glycerol.
8. Drosha storage/reaction buffer: 20 mM Tris–HCl (pH 8.0), 100 mM NaCl, 0.2 mM 
ethylenediaminetetraacetic acid (EDTA), and 10 % (v/v) glycerol.
9. Liquid nitrogen or dry ice–ethanol mix.
2.3 Transcription and Purification of pri-miRNAs Uniformly Labeled with 32P
1. The transcription template for a human pri-miR-30a fragment is a linearized 
pUC19 plasmid containing the sequence 
GAATTCTAATACGACTCACTATAGGAAAG 
AAGGTATATTGCTGTTGACAGTGAGCGACTGT 
AAACATCCTCGACTGGAAGCTGTGAAGCCACA 
GATGGGCTTTCAGTCGGATGTTTGCAGCTGC 
CTACTGCCTCGGACTTCAAGGGGCTACTTTA 
GGAGCAATTATCTTGTTTCgaagagTCTAGA (the EcoRI and XbaI cloning 
sites are underlined; the T7 promoter is in plain italic; the EarI site used for 
linearization is in lower case; and the coding sequence for the RNA is bold).
2. 10× T7 transcription buffer: 400 mM Tris–HCl pH 8.0, 250 mM MgCl2, 40 mM 
DTT, 20 mM spermidine.
3. 10× NTP mix: 20 mM ATP, 20 mM GTP, 20 mM CTP, and 5 mM UTP.
4. [α-32P] UTP (6,000 Ci/mmol, 10 mCi/mL).
5. T7 RNA polymerase.
6. Temperature-controlled dry bath and heat block.
7. 2× RNA loading dye: 1× TBE (89 mM Tris, 89 mM boric acid, 2 mM EDTA, pH 
8.3), 10 M urea, 10 mM EDTA, 0.002 % bromophenol blue, and 0.002 % xylene 
cyanol.
8. Electrophoresis system, including glass plates (20 × 20 cm), spacers and combs 
(typically 0.75 or 0.80 mm thick), gel-running apparatus, and a power supply.
9. Denaturing 15 % polyacrylamide gel solution (50 mL): 1× TBE, 7 M urea, 18.75 
mL 40 % acrylamide (acrylamide:bis-acrylamide 29:1) stock solution.
10. Tetramethylethylenediamine (TEMED), 500 μL.
11. 10 % (w/v) ammonium persulfate (APS).
12. Autoradiography film.
13. 1× TEN buffer: 10 mM Tris–HCl pH 8.0, 1 mM EDTA, 100 mM NaCl.
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14. Tube rotator.
2.4 Reconstituted pri-miRNA Processing Assays
1. RNaseOUT recombinant ribonuclease inhibitor.
2. Dry bath and electrophoresis system: Same as above.
3. Gelbond PAG film (Lonza).
4. Gel dryer, cold trap, and vacuum pump.
5. Storage phosphor screen.
6. Phosphorimager such as the Typhoon 9410 Variable Mode Imager (GE 
Healthcare).
7. Image analysis programs such as Quantity One (Bio-Rad), ImageQuant (GE 
Healthcare), or ImageJ (NIH, free online).
3 Methods
3.1 Expression of Heme-Bound DGCR8 NC1 in E. coli
1. Transform the NC1 expression plasmid to E. coli. Spread the bacteria on an LB 
agar plate with appropriate antibiotic and incubate at 37 °C overnight.
2. Inoculate a culture containing 150 mL of LB medium and appropriate antibiotic 
with a single colony. Shake at 250 rpm and 37 °C overnight.
3. Inoculate the desired volume of LB medium with antibiotic for overexpression. 
Shake at 250 rpm and 37 °C until OD600 nm reaches 1.0–1.2 as measured using a 
spectrophotometer equipped with a turbidity cuvette holder (see Note 3).
4. Induce NC1 expression by adding IPTG and δ-ALA, both to a final concentration 
of 1 mM (see Note 4). Continue to shake for 3.5–4 h at the same temperature. 
Collect the cells by centrifuging at 5,000 × g at 4 °C for 15 min. The pellets should 
have a noticeable brown color.
5. Store the pellets at −80 °C.
3.2 Purification of NC1
1. Completely resuspend cell pellet in ice-cold DGCR8 lysis buffer (40 mL per L of 
culture).
2. Sonicate the cell suspension using the ultrasonic processor at 80 % power, 1-s on 
and 1-s off, for a total of 7–8 min. To avoid overheating the lysate, a 30-s break is 
taken after each minute of sonication and the container is kept on ice at all times.
3Measuring OD600 nm of cell cultures using a spectrophotometer with a turbidity cuvette holder is more accurate than without, 
because most of the scattered light is blocked by the turbidity cuvette holder. The absolute values of OD600 nm depend on the 
instrument used. The bacterial cell density we use in NC1 expression is similar to that commonly recommended for protein 
expression.
4δ-ALA is a key heme biosynthesis intermediate. In the absence of δ-ALA, NC1 is expressed as a mixture of heme-bound dimer and 
heme-free “monomer” [4]. Addition of δ-ALA increases the yield of NC1 expression and improves the heme content of NC1 to the 
extent that often little or no heme-free “monomer” is observed.
Barr and Guo Page 6
Methods Mol Biol. Author manuscript; available in PMC 2016 March 11.
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
3. Centrifuge the lysate at 45,000 × g for 30 min at 4 °C.
4. Load the supernatant onto a HiTrap SP column equilibrated with DGCR8 buffer A. 
Elute using a linear gradient of DGCR8 buffers A and B. The protein elutes at 
around 300 mM NaCl (10 % DGCR8 buffer B). The fractions containing heme-
bound NC1 have a yellowish-brown color. Analyze the purity of the fractions using 
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE).
5. If the peak fractions are not >90 % pure, repeat the ionexchange chromatography 
step. Pool the fractions containing relatively pure NC1. Dilute it 1:1 (v:v) with 
DGCR8 buffer A to reduce the salt concentration. Repeat step 4. The protein may 
be stored at 4 °C overnight if desired.
6. Equilibrate the Superdex 200 column in SEC buffer (roughly 50 mL). Concentrate 
the fractions from the last ion-exchange chromatography step down to ~550 μL 
using a centrifugal concentrator. Filter the concentrated NC1 solution through a 
membrane with 0.2 μm pores, and load the filtrate onto the column. Collect 0.5 mL 
fractions. Heme-bound NC1 dimer elutes at around 12.5 mL (see Note 5).
7. Determine the NC1 protein concentration using UV-visible absorption 
spectroscopy. Blank the spectrophotometer with SEC buffer. Scan between 240 and 
700 nm. An absorption peak at 280 nm indicates that bacterial nucleic acids have 
been successfully removed from the protein. NC1 dimer concentration = A280 nm/
ε280 nm. Based on the amino acid sequence, ε280 nm is estimated to be 94.5 mM−1 
cm−1 (ε280 nm,apo) [35]. This value has been used in all our previous publications. 
However, our recent unpublished measurements using microBCA assay indicate 
ε280 nm ≈ 130 mM−1 cm−1 (see Note 6).
8. Calculate the A450 nm/A280 nm ratio. If majority (>60 %) of the NC1 protein is 
occupied by heme, A450 nm/A280 nm should be between 0.40 and 0.53 (the higher the 
better). NC1 preparations with lower A450 nm/A280 nm ratios are less active (see 
Notes 7 and 8).
9. The Fe(III) heme-bound NC1 protein may be stored at 4 °C, with protection from 
light. Because this protein gradually loses pri-miRNA processing activity for 
5Presence of 1 mM DTT or 10 mM β-mercaptoethanol in the SEC buffer helps remove the residual amount of nucleic acids bound to 
NC1 during size exclusion chromatography using the Superdex 200 column. Under this condition, the free nucleic acids elute at >20 
mL, a volume too large for macromolecules. There seems to be an unusual interaction between nucleic acids and the resin in the 
presence of thiol-containing reducing reagents.
6Heme absorbs at 280 nm. Thus, it is not surprising that ε280 nm of the Fe(III) heme–NC1 complex (ε280 nm,holo) is higher than that 
of the protein alone calculated from the amino acid sequence (ε280 nm,apo).
7The extinction coefficient for the 450 nm peak of NC1 is 74 mM−1 cm−1 [30]. This value was determined using the pyridine 
hemochromagen assay [37] and should be used instead of the previously reported value (58 mM−1 cm−1) [4].
8The heme occupancy (Oheme) may be calculated using the following equation:
where the ε450 nm of NC1 is 74 mM−1 cm−1 [30].
Barr and Guo Page 7
Methods Mol Biol. Author manuscript; available in PMC 2016 March 11.
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
reasons not well understood, we typically use it within a couple of days from the 
completion of purification.
3.3 Expression and Purification of Recombinant Homo Sapiens His6-Drosha390–1374
1. His6-Drosha390–1374 is expressed in Sf9 insect cells using a baculovirus system, 
following Invitrogen’s standard protocols. The cell pellets are stored in −80 °C 
freezer until purification.
2. Resuspend a pellet from 50 mL of insect cell culture in 30 mL of ice-cold Drosha 
lysis buffer. Sonicate at 50 % power, 1-s on and 1-s off, for a total of 4 min. To 
avoid overheating the lysate, a 30-s break is taken after each minute of sonication 
and the container is kept on ice throughout the sonication procedure.
3. Centrifuge the lysate at 45,000 × g for 30 min at 4 °C.
4. Load the supernatant onto a Ni Sepharose High Performance column. Wash the 
column extensively using the Drosha wash buffer, and elute the His6-
Drosha390–1374 protein in the Drosha elution buffer.
5. Dialyze the purified His6-Drosha390–1374 against the Drosha storage/reaction 
buffer.
6. Aliquot in 10 μL per tube, freeze in liquid nitrogen or dry ice–ethanol mix, and 
store in −80 °C freezer.
3.4 Transcription and Purification of pri-miRNAs Uniformly Labeled with 32P
1. Set up the transcription reaction by adding the following:
10 μL H2O.
2 μL 10× transcription buffer.
2 μL 10× NTP mix.
2 μL DNA template.
2 μL [α-32P] UTP.
2 μL T7 RNA polymerase (always add last).
Incubate the transcription reaction at 37 °C for 2–3 h.
2. Add 20 μL 2× RNA loading dye to the reaction.
3. Pour a denaturing 15 % polyacrylamide gel (1× TBE, 7 M urea). Assemble the gel 
sandwich. Induce polymerization of the 50 mL gel mix by adding 50 μL TEMED 
and 500 μL 10 % APS. Pour the gel, insert the comb, and let stand at room 
temperature for 1 h. Mount the gel on the electrophoresis apparatus. Pre-run the gel 
in 1× TBE at a constant power of 12 W for 20 min.
4. Load the transcription onto the gel. Run the gel at 12 W until the bromophenol blue 
reaches the bottom of the gel. Disassemble gel sandwich, and leave the gel attached 
to one glass plate.
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5. Cover the gel with a plastic wrap. Expose the gel to an autoradiography film. 
Excise out the band. Expose the gel to another film to confirm the excision.
6. Crush and soak the gel piece in 1× TEN buffer at 4 °C for at least 10 h.
7. Precipitate the RNA by adding 3 volumes of ethanol and 0.1 volume of 3 M 
sodium acetate pH 5.2. Resuspend the RNA in H2O.
8. Determine radioactivity using scintillation counting. Dilute the RNA to ~10,000 
cpm/μL in water prior to the processing assay.
3.5 pri-miRNA Processing Assay
1. Set up a 10-μL processing reaction by mixing the following (in the order shown):
4.5 μL Drosha storage/reaction buffer.
2 μL recombinant His6-Drosha390–1374 (~2 ng/μL).
1 μL Fe(III) heme-bound NC1 (10× stock).
0.5 μL RNaseOUT (40 U/μL).
1 μL 64 mM MgCl2.
1 μL pri-miRNA (~10,000 cpm/μL).
For Drosha-only control, the NC1 stock solution should be replaced by SEC 
buffer. For NC1-only control, Drosha storage/reaction buffer should be used 
instead of the recombinant Drosha protein (see Note 9).
2. Incubate at 37 °C for 45 min. The reactions generally do not proceed further after 1 
h. Add 10 μL 2× RNA loading dye to stop the reaction.
3. Analyze the reactions using a denaturing 15 % polyacrylamide gel (1× TBE, 7 M 
urea). Follow steps 3 and 4 in Subheading 3.4, Transcription and purification of 
pri-miRNAs.
4. Adhere the disassembled gel on the hydrophobic surface of a Gelbond film (see 
Note 10). Cover the other side of the gel with a filter paper. Dry the gel using a gel 
dryer coupled to a cold trap and a vacuum pump.
5. Expose the gel to a storage phosphor screen overnight.
6. Scan in the image using a phosphorimager. An example image is shown in Fig. 3.
7. Quantify the total intensities of substrate and product bands using an image 
analysis program. Background intensities are subtracted. To calculate the fraction 
of pri-miRNA processed, the signals from the pre-miRNAs (see Note 11) are first 
converted to that of its corresponding pri-miRNA by multiplying the ratio of U 
9The above reaction can also be set up anaerobically using an anaerobic chamber to prepare the protein sample and a gastight syringe 
to transfer the pri-miRNA to the sample [6]. To do kinetic assay, increase the above volumes and take aliquots at desired intervals.
10Polyacrylamide gels ≥15 % do not stick strongly to filter paper typically used in gel drying protocols but adhere to the hydrophobic 
surface of the Gelbond film. Note that this surface is opposite to the treated hydrophilic side that is designed to cross-link with 
acrylamide.
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residues in pri-miRNA and pre-miRNA, since the pri-miRNAs were uniformly 
labeled using [α-32P] UTP. For example, the ratio is 42/16 = 2.625 for the 150-nt 
pri-miR-30a fragment as we used previously [22]. The signal of pri-miRNA 
processed is then divided by the amount of starting substrate.
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Fig. 1. 
Domain structures and recombinant expression constructs of human Drosha and DGCR8. 
The heme-binding domain (HBD) of DGCR8 includes a dimerization (sub)domain (DD)
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Fig. 2. 
Electronic absorbance spectrum of Fe(III) heme-bound NC1 dimer. The solid line, 
corresponding to the left y-axis, shows the relative absorbencies of the heme and protein 
peaks. The dashed line, corresponding to the right y-axis, shows the extinction coefficients 
of the heme, as determined using the pyridine hemochromagen assay as recently reported 
[30]
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Fig. 3. 
Example of a pri-miRNA processing assay. Uniformly labeled pri-miR-30a was incubated 
with 4 nM His6-Drosha390–1374, either alone (lane 2) or with 50 nM Fe(III) heme-bound 
NC1 dimer (lane 3), at 37 °C for 45 min. The reactions were analyzed using a 7 M urea, 15 
% polyacrylamide gel. LMWM: low molecular weight marker
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